MRNA Exercise Disclosure
Mock James M · SEC Form 4 · Filed Sep 14, 2026
Exercise
Calculated transaction value
$0
Mock James M Chief Financial Officer
MRNA
Moderna
MRNA
Transaction date
Sep 10, 2026
Public filing date
Sep 14, 2026
Filing lag
Filed 4 days later
MRNA daily price context
Close on/before transaction
$136.62
Sep 10, 2026
Close before public filing
$143.97
Sep 11, 2026
Return since public filing
+2.03%
Through Sep 14, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock Option (Right to Buy) on Common Stock
- Quantity / price
- 19,836 shares @ $0
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001682852-26-000174
Filing cohort
Transactions in this filing
Showing 4 of 4
Trades
4
Issuers
1
Estimated value
$5.3M
Buys / sales
0 / 2
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Moderna, Inc. MRNA | Exercise | Sep 10, 2026 | $614.12K |
| Moderna, Inc. MRNA | Sale | Sep 10, 2026 | $2.67M |
| Moderna, Inc. MRNA | Sale | Sep 10, 2026 | $2.02M |
| Moderna, Inc. MRNA Current | Exercise | Sep 10, 2026 | $0 |